PA
IRMD icon

Parallel Advisors’s iRadimed IRMD Stock Holding History

Parallel Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.3K Buy
180
+107
+147% +$10.7K ﹤0.01% 2534
2025
Q4 		$7.1K Buy
73
+7
+11% +$601 ﹤0.01% 2739
2025
Q3 		$4.7K Buy
66
+41
+164% +$2.73K ﹤0.01% 2803
2025
Q2 		$1.5K Buy
25
+16
+178% +$877 ﹤0.01% 3114
2025
Q1 		$472 Hold
9
– – ﹤0.01% 3244
2024
Q4 		$495 Hold
9
– – ﹤0.01% 3225
2024
Q3 		$453 Buy
9
+6
+200% +$277 ﹤0.01% 3196
2024
Q2 		$132 Buy
+3
New +$128 ﹤0.01% 3236
2022
Q2 		– Sell
-2
Closed – – 3163
2022
Q1 		$0 Sell
2
-55
-96% -$2.54K ﹤0.01% 3112
2021
Q4 		$3K Buy
+57
New +$2.3K ﹤0.01% 2584

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallel Advisors's IRMD Position: Q1 2026 in Review

Parallel Advisors increased its iRadimed (IRMD) stake by 147% in Q1 2026, buying an estimated $10.7K and bringing the position to 180 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

Parallel Advisors first reported a position in IRMD in Q4 2021 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Parallel Advisors held 180 shares of iRadimed worth $17.3K as of Q1 2026.
  • Parallel Advisors bought 107 iRadimed shares in Q1 2026, an estimated $10.7K.
  • iRadimed made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2534 holding.
  • Parallel Advisors first reported a position in iRadimed in Q4 2021 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.